Background: Mother-to-infant transmission is the leading cause of childhood hepatitis C
virus (HCV) infection, with up to 4000 new cases each year in the United States. Purpose: To …

Four virological markers of hepatitis C virus (HCV) infection are used clinically for
management of patients with hepatitis C, namely the HCV genotype, HCV RNA, HCV core …

These guidelines for the treatment of persons who have or are at risk for sexually transmitted
diseases (STDs) were updated by CDC after consultation with a group of professionals …

These guidelines for the treatment of persons who have sexually transmitted diseases
(STDs) were developed by CDC after consultation with a group of professionals …

The global prevalence of viral hepatitis is very high and seems to be rising over the years.
The infection can profoundly affect pregnant women causing significant maternal and …

Mother-to-infant transmission of hepatitis C virus (HCV) is comparatively uncommon. The
prevalence of antibody to HCV (anti-HCV) in pregnant women is 0.1% to 2.4%, although in …

Molecular biology-based assays are invaluable tools for the management of chronic viral
hepatitis. They can be used to test blood donations, diagnose active infection, help to …

Encouraging efficacy data have been obtained in the hepatitis C virus (HCV) chimpanzee
model using prophylactic vaccines comprising adjuvanted recombinant envelope …

In industrialized countries, hepatitis C virus (HCV) is the most common cause of chronic liver
disease in children. Perinatal transmission is the leading cause of infection. Perinatal …

Hepatitis C virus (HCV) is a single-stranded RNA virus that belongs to the family Flaviviridae
(6). HCV was initially recognized as non-A, non-B hepatitis virus (NANBH) in 1974 until …